https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue34s,Article28.pdf
International Journal of Drug Delivery Technology · 29.05.2026 · 16 (34s)
DOI: 10.25258/ijddt.16.34s.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.05.2026. Verfasst von Vaishnavi Saste und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Inflammation is a complex biological response associated with various chronic and acute disorders. Although conventional anti-inflammatory drugs are widely used, their long-term use is often associated with adverse effects. Hence, there is a growing interest in plant-based therapeutics. Ficus racemosa L., traditionally used in Ayurveda, possesses diverse pharmacological properties; however, its anti-inflammatory potential, particularly of the bark, remains underexplored.
Objective
The present study aimed to evaluate the in vitro anti-inflammatory activity of Ficus racemosa bark extracts using the protein denaturation method.
Methods
Hot and cold aqueous extracts of Ficus racemosa bark were prepared and tested at varying concentrations (0.01–1000 µg/mL). Anti-inflammatory activity was assessed using the egg albumin denaturation assay. Diclofenac and prednisolone were used as reference standards. Absorbance was measured at 680 nm, and percentage inhibition of protein denaturation was calculated. Statistical analysis was performed using SPSS software with significance set at P < 0.05.
Results
Both extracts exhibited significant inhibition of protein denaturation in a concentration-dependent manner. The hot water extract demonstrated comparatively higher inhibitory activity at lower concentrations (0.01 and 0.1 µg/mL). Notably, both extracts showed significantly greater inhibition than the reference drugs at higher concentrations (P < 0.05). Maximum inhibition was observed at 1000 µg/mL.
Conclusion
The findings indicate that Ficus racemosa bark possesses potent in vitro anti-inflammatory activity, surpassing standard drugs in the protein denaturation model. This supports its traditional use and highlights its potential as a natural anti-inflammatory agent. Further in vivo and mechanistic studies are warranted to validate these findings.
Zitieren
APA
Saste, V., Mapari, R., Bobade, R., Mante, A., Magar, S., Lodhe, N., Gite, A., Mohrut, S., Sawadadkar, N., & Kayande, N. (2026). https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue34s,Article28.pdf. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.27
Vancouver
Saste V, Mapari R, Bobade R, Mante A, Magar S, Lodhe N, et al. https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue34s,Article28.pdf. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.27
BibTeX
@article{Saste2026,
author = {Saste, Vaishnavi and Mapari, Revati and Bobade, Rahul and Mante, Arun and Magar, Samadhan and Lodhe, Nitin and Gite, Ananta and Mohrut, Shivaji and Sawadadkar, Nilesh and Kayande, Nandu},
title = {https://impactfactor.org/PDF/IJDDT/16/IJDDT,Vol16,Issue34s,Article28.pdf},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {34s},
doi = {10.25258/ijddt.16.34s.27}
}
EUVIMED